Influenza A virus A/Hong Kong/4801/2014 (H3N2) recombinant hemagglutinin antigen

DB14417ApprovedInvestigationalWithdrawnVaccines

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".

First approval: United States, 2016

Resolves to

Compound

UNII2I1EOL437M

What you can answer from here — as of April 02, 2025

15Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

3Marketed productsAcross 1 country and 1 labeller

Which other approved drugs treat the same conditions as Influenza A virus A/Hong Kong/4801/2014 (H3N2) recombinant hemagglutinin antigen, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account